Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia
Top Cited Papers
Open Access
- 27 May 2009
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 301 (20), 2120-2128
- https://doi.org/10.1001/jama.2009.722
Abstract
With the advent of proton-pump inhibitors, the use of acid-suppressive medications has increased significantly over the last several years, particularly in the inpatient setting. Studies evaluating the prevalence of acid-suppressive medication estimate that between 40% and 70% of medical inpatients receive some form of acid-suppressive medication during their hospitalization, approximately 50% of which are initiations.1,2 Furthermore, approximately half of those newly prescribed acid-suppressive medication in the hospital are subsequently discharged with a prescription for these medications.1,3,4Keywords
This publication has 31 references indexed in Scilit:
- Stress-ulcer prophylaxis for general medical patients: A review of the evidenceJournal of Hospital Medicine, 2007
- Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based StudyClinical Infectious Diseases, 2006
- Hospital‐acquired gastrointestinal bleeding outside the critical care unit: Risk factors, role of acid suppression, and endoscopy findingsJournal of Hospital Medicine, 2006
- Inadequate Use of Acid-Suppressive Therapy in Hospitalized Patients and Its Implications for General PracticeDigestive Diseases and Sciences, 2005
- Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?Current Surgery, 2004
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- Effect of Lansoprazole on Human Leukocyte FunctionImmunopharmacology and Immunotoxicology, 1999
- Activity Inhibition of Cytolytic Lymphocytes by OmeprazoleScandinavian Journal of Immunology, 1996
- The effect of omeprazole on human natural killer cell activityGeneral Pharmacology: The Vascular System, 1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987